Q5116 Injection., trazimera, 10 milligrams
Also known as: Trazimera injection, trastuzumab-qyyp
Injection of Trazimera, trastuzumab-qyyp biosimilar per 10 milligrams, for HER2-positive cancer treatment.
In Plain Language
breast cancer therapy injection; targeted cancer drug
Clinical Context
Indicated for HER2-positive breast cancer and gastric cancer management.
RVU Information
CPT Q5116 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5116?
CPT Q5116 (Injection., trazimera, 10 milligrams) is a Q Codes code. Injection of Trazimera, trastuzumab-qyyp biosimilar per 10 milligrams, for HER2-positive cancer treatment.
Is Q5116 covered by insurance?
Q5116 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Indicated for HER2-positive breast cancer and gastric cancer management.
When is CPT Q5116 used?
Indicated for HER2-positive breast cancer and gastric cancer management.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.